EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection

Anastasios Tentolouris, Christos Siafarikas, Ioannis Ntanasis-Stathopoulos, Ioanna A Anastasiou, Eirini Kalara, Alexandros Briasoulis

Primary Care Diabetes · 2026

DOI: 10.1016/j.pcd.2026.01.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Primary Care Diabetes, 2026. Verfasst von Anastasios Tentolouris und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Propaedeutic Internal Medicine and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, Laiko Gen…. Hauptthemen laut MEDLINE: Tirzepatide, Prediabetic State, Glucagon-Like Peptides, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatidePrediabetic StateGlucagon-Like PeptidesCardiovascular DiseasesBlood GlucoseHypoglycemic AgentsDiabetes Mellitus, Type 2IncretinsHumansSemaglutideTreatment OutcomeBiomarkersRisk Factors

Stichwörter der Autor:innen

Cardiovascular DiseaseDiabetes PreventionGLP-1-Based TherapiesPrediabetesSemaglutideTirzepatide

Substanzen

SemaglutideTirzepatideGlucagon-Like PeptidesBlood GlucoseHypoglycemic AgentsBiomarkersIncretins

Autor:innen und Institutionen

  • First Department of Propaedeutic Internal Medicine and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece. Electronic address: antentol@med.uoa.gr.
  • First Department of Propaedeutic Internal Medicine and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
  • Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece.

Zitieren

APA

Tentolouris, A., Siafarikas, C., Ntanasis-Stathopoulos, I., Anastasiou, I. A., Kalara, E., & Briasoulis, A. (2026). Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2026.01.003

Vancouver

Tentolouris A, Siafarikas C, Ntanasis-Stathopoulos I, Anastasiou IA, Kalara E, Briasoulis A. Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection. Primary Care Diabetes. 2026. doi:10.1016/j.pcd.2026.01.003

BibTeX
@article{Tentolouris2026,
  author = {Tentolouris, Anastasios and Siafarikas, Christos and Ntanasis-Stathopoulos, Ioannis and Anastasiou, Ioanna A and Kalara, Eirini and Briasoulis, Alexandros},
  title = {Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection},
  journal = {Primary Care Diabetes},
  year = {2026},
  doi = {10.1016/j.pcd.2026.01.003}
}
Kostenlos starten →